Interferon/long‐term lamivudine combination therapy in anti‐HBe positive chronic hepatitis B patients

Abstract

Combination therapy appears to be effective and may also delay the selection of lamivudine-resistant variants. However, controlled trials are definitely warranted to clarify the potential benefits of combination antiviral treatment over monotherapy.